Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
3.335
-0.095 (-2.77%)
At close: Apr 28, 2026, 4:00 PM EDT
3.260
-0.075 (-2.25%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Indaptus Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 10.49 | 8.11 | 8.76 | 8.59 | 5.21 | |
| Research & Development | 9.34 | 7.25 | 7.62 | 6.32 | 2.52 | |
| Operating Expenses | 19.83 | 15.37 | 16.38 | 14.91 | 7.73 | |
| Operating Income | -19.83 | -15.37 | -16.38 | -14.91 | -7.73 | |
| Other Non Operating Income (Expenses) | -1.02 | 0.34 | 0.96 | 0.59 | 0.02 | |
| Pretax Income | -20.85 | -15.02 | -15.42 | -14.32 | -7.71 | |
| Net Income | -20.85 | -15.02 | -15.42 | -14.32 | -7.71 | |
| Net Income to Common | -20.85 | -15.02 | -15.42 | -14.32 | -7.71 | |
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | |
| Shares Change (YoY) | 189.14% | 11.36% | 1.68% | 101.98% | 110.35% | |
| EPS (Basic) | -21.58 | -44.96 | -51.41 | -48.54 | -52.78 | |
| EPS (Diluted) | -21.58 | -44.96 | -51.41 | -48.54 | -52.78 | |
| Free Cash Flow | -14.82 | -12.32 | -13.41 | -13.08 | -11.29 | |
| Free Cash Flow Per Share | -15.34 | -36.88 | -44.68 | -44.32 | -77.31 | |
| EBITDA | -19.83 | -15.37 | -16.38 | -14.91 | -7.73 | |
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0 | |
| EBIT | -19.83 | -15.37 | -16.38 | -14.91 | -7.73 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.